NCT01435798 Clinical Trial Information | SourceSolution's Biotech, Pharma, CMO, CRO Directory

Clinical Neuropharmacology of Pain in Spinal Cord Injury


Sponsors: Brigham and Women's Hospital	Phases: Phase II
Indications	Acronym:
Neuralgia Allodynia Spinal Cord Injury
Age Groups: Adult Senior	Gender: Both
Names: Drug: Dextromethorphan placebo, Lidocaine placebo Drug: Dex1Lido2 Drug: Dex1Lido3 Drug: Dex1Lido4 Drug: Dex2Lido1 Drug: Dex2Lido2 Drug: Dex2Lido3 Drug: Dex2Lido4 Drug: Dex3Lido1 Drug: Dex3Lido2 Drug: Dex3Lido3 Drug: Dex3Lido4 Drug: Dex4Lido1 Drug: Dex4Lid	Enrollment: 24

Additional information about NCT01435798.